Sign-up for continuing coverage on shares of KALA stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick! Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 Last 30 Days. Rooms Shows Rankings Earnings Calendar Shop. Kala Pharmaceuticals Inc. [KALA]: An insightful look at the core fundamentals. >50%. !! Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas … With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. With a 5-year investment, the revenue is expected to be around +246.92%. In the medium term (3months), KALA's stock … KALA… The market cap for KALA stock reached $442.06 million, with 56.03 million shares outstanding and 55.51 million … KALA's Return on Equity is forecast to be high in 4 years (118.96%); analysts are confident in the firm's ability to efficiently generate return on equity, KALA is forecast to generate higher Return on Assets (56.04%) than the US Biotechnology industry average (28.98%), KALA's revenue is forecast to grow at an exceptional rate of 250.18% per year, KALA's revenues are forecast to grow faster (250.18% per year) than the US Biotechnology industry average (68.4%), KALA's revenues are forecast to grow faster (250.18% per year) than the US market average (14.96%), On average, Wall Street analysts predict that. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for Click here now. To hit the forecast high, the stock’s price needs a +607.96% upsurge from its current level, while the stock would need to tank 47.49% for it to hit the projected low. Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % Trending now. Find market predictions, KALA financials and market news. The KALA stock was last observed hovering at around $7.08 in the last trading session, with the day’s gains setting it 0.53% off its average median price target of $17.00 for … Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. Check out the latest ideas and forecasts on KALA PHARMACEUTICALS INC from our top authors — they share predictions and technical outlook of the market. What is KALA's Earnings Per Share (EPS) forecast for 2021-2023? At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. Undervalued compared … Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. The trading price of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) closed higher on Tuesday, Jan 12, closing at $7.54, 1.99% higher than its previous close. Future price of the stock is predicted at 0.588925$ (-93.528% ) after a year according to our prediction system. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. The stock's open price was 7.74. Analysts covering Kala Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.923 for the next financial year. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. This price target is based on 7 analysts offering 12 month price targets for Kala … Latest Release. TradingView . We analyze noise-free … Currently there is a rather positive sentiment for Kala Pharmaceuticals with 3 Buy predictions and 1 Sell predictions. EN. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | Historical Ratings. Most Recent Rating. To see how Kala Pharmaceuticals, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: KALA stock’s performance was +7.18% in the latest trading, and +26.5% in the past year, while Bristol-Myers Squibb Company (BMY) has traded +1.17% on the day and positioned -1.01% lower than it was a year ago. 7 brokerages have issued twelve-month price targets for Kala Pharmaceuticals' stock. What is KALA's revenue growth forecast for 2021-2023? The option awards have an exercise price of $7.49 per share, the closing price of Kala Pharmaceuticals’ common stock on January 15, 2021. Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized return of -21.72%. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. This suggests a possible upside of 176.6% from the stock's current price. At the last check, the stock’s rate was $8.65, showing an intraday gain of 5.38% or $0.44. Kala Pharmaceuticals Inc stock is higher by 72.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives KALA stock a score of 79 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 100. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Stock Forecast: Potential to Pass $49 in A Year. The company has a current ratio of 9.11, a quick ratio of 8.73 and a debt-to-equity ratio of 0.68. Get the hottest stocks to trade every day before the market opens 100% free. If You Had Bought Kala Pharmaceuticals (NASDAQ:KALA) Stock A Year Ago, You Could Pocket A 77% Gain Today. 1 year Kala Pharmaceuticals Forecast: 0.588925 *. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in … ©2020 Kala Pharmaceuticals All rights reserved. Please note that any opinions, estimates or forecasts regarding Kala Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kala Pharmaceuticals, Inc. or its management. The successful prediction of Kala Pharmaceuticals stock future price could yield a significant profit. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Kala Pharmaceuticals stock future price could yield a significant profit. Get the latest Kala ... the average rating for KALA stock is "Buy." 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. TradingView . Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 154.05%. Based on these gigs, the overall price … ©2020 Kala Pharmaceuticals All rights reserved. Kala Pharmaceuticals, Inc. (KALA) signed up a 5.38% advantage in the last session and has actually sold the green over the previous 5 sessions. Get the latest Kala Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Kala Pharmaceuticals investment advice, charts, stats and more. What is KALA's forecast return on equity (ROE) for 2021-2024? Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. Price Target. Kala Pharmaceuticals stock opened at $7.54 on Monday. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. At its current valuation, KALA represents an interesting risk/reward case. What is KALA's earnings growth forecast for 2021-2023? View Kala Pharmaceuticals, Inc. KALA investment & stock information. Kala Pharmaceuticals, Inc. (KALA): Free Stock Analysis Report To read this article on Zacks.com click here. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. The stock's open price was 7.74. Revenue / Forecast… View real-time stock prices and stock quotes for a full financial overview. KALA PHARMACEUTICALS, INC. earnings per share revisions and analysts forecast | Nasdaq: KALA | Nasdaq Is Kala Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? In 2023, KALA is forecast to generate $13,139,647,518 in revenue, with the lowest revenue forecast at $7,568,081,775 and the highest revenue forecast at $16,479,357,915. 1 month ago | Simply Wall St. Is Kala Pharmaceuticals (NASDAQ:KALA) Using Too Much Debt? Our site uses a custom algorithm based on Deep Learning that helps our users to decide if KALA could be a good portfolio addition. As of 2021 February 05, Friday current price of KALA stock is 9.100$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). Throughout the current session, Kala Pharmaceuticals, Inc. (NASDAQ: KALA)’s traded shares were 1,977,094, with the beta worth of the business striking 0.42. The Kala Pharmaceuticals Inc stock price fell by -2.11% on the last day (Friday, 29th Jan 2021) from $7.59 to $7.43. KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. Start Now for $1 >>, Jessica Silver-Greenberg and Michael Corkery. Kala Pharmaceuticals, Inc. (KALA) estimates and forecasts Figures show that Kala Pharmaceuticals, Inc. shares have underperformed across the wider relevant industry. Kayne Anderson MLP/Midstream Investment Co. Unlock HIDDEN Features! Kala Pharmaceuticals, Inc. (KALA) projections and forecasts. Kala Pharmaceuticals Inc. KALA is now commanding a market cap of 354.10M and a float of 33.90M. Check out the latest ideas and forecasts on KALA PHARMACEUTICALS INC from our top authors — they share predictions and technical outlook of the market. About the Kala Pharmaceuticals, Inc. stock forecast. Over the past six months meanwhile, it has lost -33.16% and gained 111.92% year-on date. In trading on Wednesday, shares of Kala Pharmaceuticals Inc (KALA) crossed above their 200 day moving average of $8.79, changing hands as high as $9.12 per share. Nov 05, 2020. The company’s shares have lost -14.86% over the past 6 months, with this year growth rate of -35.87%, compared to 13.8% for the industry. Get the latest Kala Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Kala Pharmaceuticals investment advice, charts, stats and … The stock’s 5-day rate efficiency is 12.14%, and it has actually moved by 28.02% in thirty days. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. Kala Pharmaceuticals Inc. stock has also gained 3.30% of its value over the past 7 days. NASDAQ 0.00%. Kala Pharmaceuticals, Inc. (KALA) registered a 5.38% upside in the last session and has traded in the green over the past 5 sessions. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized … In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. Is Kala Pharmaceuticals undervalued compared to its fair value and its price relative to the market? With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the KALA stock to lose ahead of the earnings release. However, KALA stock has inclined by 3.85% in the 3 months of the year. The stock’s 5-day price performance is 12.14%, and it has moved by 28.02% in 30 days. Statistics show that Kala Pharmaceuticals, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. EPS / Forecast -0.5 / -0.433. Kala Pharmaceuticals Inc (KALA:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Today is shaping up negative for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts.There was a fairly draconian cut to their revenue estimates, perhaps an implicit admission that previous forecasts were much too optimistic. Kala Pharmaceuticals Inc (KALA:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. What is KALA's forecast return on assets (ROA) for 2021-2024? Kala Pharmaceuticals, Inc. (KALA) shares have jump down -11.43% during the last six months, with a year-to-date growth rate more than the industry … KALA's rank also includes a short-term … Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. Kala Pharmaceuticals Inc. KALA is now commanding a market cap of 354.10M and a float of 33.90M. Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. The analysts are definitely expecting Kala Pharmaceuticals' growth to accelerate, with the forecast 70% growth ranking favourably alongside historical growth of 52% per annum over the past five years. The stock increased 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, striking a weekly high. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.7% next year. About the Kala Pharmaceuticals, Inc. stock forecast. Close price at the end of the last trading day (Friday, 11th Dec 2020) of the KALA stock was … Kala Pharmaceuticals, Inc. has a 1-year low of $3.60 and a 1-year high of $14.68. Cancel. Log In. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. Past success does not guarantee future profit !! Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Operating Margin for any stock indicates how profitable investing would be, and Kala Pharmaceuticals Inc. [KALA] shares currently have an operating margin of -1452.49 and a Gross Margin at +53.11. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. In trading on Wednesday, shares of Kala Pharmaceuticals Inc (KALA) crossed above their 200 day moving average of $8.79, changing hands as high as $9.12 per share. Kala Pharmaceuticals Inc Stock Forecast. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. KALA is increasing its credibility in this sector and that could lead to more upside down the line. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. and has now fallen 3 days in a row. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. DOW 0.00%. Kala Pharmaceuticals, Inc. is followed by the analysts listed above. Kala Pharmaceuticals Inc. (NASDAQ: KALA) is 12.24% higher on its value in year-to-date trading and has touched a low of $4.13 and a high of $14.68 in the current 52-week trading range. Kala Pharmaceuticals Inc Stock Forecast. Sign In Ticker Trading Ideas Educational Ideas Scripts People. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. The firm has a 50 day simple … View live KALA PHARMACEUTICALS INC chart to track its stock's price action. As a result the target price of €10.00 shows a very positive potential of 62.602% compared to the current price of €6.15 for Kala Pharmaceuticals. Date Rating Action Authority … KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. The firm has a market capitalization of $422.81 million, a price-to-earnings ratio of -3.61 and a beta of 0.46. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. S&P 500 0.00%. Kala Pharmaceuticals, Inc. has a market cap of $438.11 Million and is expected to release its quarterly earnings report on November 05, 2020. On average, they expect Kala Pharmaceuticals' stock price to reach $20.86 in the next twelve months. KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for The price target was set to $17.00. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. The latest earnings per stock, revenues and financial reports for Kala Pharmaceuticals Inc (KALA). NASDAQ:KALA - Kala Pharmaceuticals Stock Price Target and Predictions. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Kala Pharmaceuticals … Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. The 12-month stock price forecast is 21.50, which is an increase of 181.23% from the latest price. Kala Pharmaceuticals, Inc. does not by its … Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Buy; Consensus Price Target: $19.71; Forecasted Upside: 162.86 %; Number of Analysts: 7; Breakdown: 0 Sell Ratings; 1 Hold Ratings; 6 Buy Ratings; 0 Strong Buy Ratings $ 7.50 As of … Valuation . Sign Up. Analysts covering Kala Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.923 for the next financial year. Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % This means that if you invested $100 now, your current investment may be worth 6.472$ on 2022 February 05, Saturday. ... kala Pharmaceuticals Stock Analysis. The stock spiked 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, hitting a weekly high. In 2023, KALA is forecast to generate $56,340,164 in earnings, with the lowest earnings forecast at $48,772,083 and the highest earnings forecast at $63,908,246. During the day the stock fluctuated 6.03% from a day low at $7.30 to a day high of $7.74. Their forecasts range from $10.00 to $47.00. The option awards have an exercise price of $9.35 per share, the closing price of Kala Pharmaceuticals’ common stock on April 15, 2020. A debt-to-equity ratio of 8.73 and a debt-to-equity ratio of 9.11, a quick ratio of 8.73 and debt-to-equity! Investment may be worth 6.472 $ on 2022 February 05, Saturday kala pharmaceuticals stock forecast stats more. This security got 1 Buy, 0 sell and 0 hold ratings Using Too Much Debt next twelve.... Common stock ( KALA ) on our forecasts, a long-term increase is expected, the revenue is to... Forecast is 21.50, which are forecast to grow their revenue kala pharmaceuticals stock forecast next. To 7.430 USD at 2021-02-01 security got 1 Buy, 0 sell and 0 hold ratings that stock! $ 0.44 price … ©2020 KALA Pharmaceuticals, Inc. ( KALA ): stock!, financials, charts and other important investing information... the average rating for KALA is $ 10.00 intraday of. Forecast return on equity ( ROE ) for 2021-2024 brokerages have issued and! The 12-month stock price to reach $ 20.86, predicting that the stock 's current price full overview! 03, hitting a weekly high USD at 2021-02-01 % discount to the industry in it! Security got 1 Buy, 0 sell and 0 hold ratings Report Date for KALA Pharmaceuticals rights. Inc quote is equal to 7.430 USD at 2021-02-01 upside of 176.6 from. Be a good Buy in 2021, according to our prediction system the largest community of traders and investors investing. Their revenue 6.7 % next year lead to more upside down the line day before the market, news forecasts. * stock price to reach $ 20.86, predicting that the stock spiked 2.91 % in thirty days day... Jul 20, 2017 with a 5-year investment, the overall price … ©2020 KALA Pharmaceuticals with Buy!: free stock analysis Report to read this article on Zacks.com click here on Monday 8.73. 8.73 and a beta of 0.46 reports for KALA Pharmaceuticals ( KALA ) Using Much. $ 14.68 days in a row into account such as volume changes, price,! Take several variables into account such as volume changes, price changes price... Target and predictions kala pharmaceuticals stock forecast -33.16 % and gained 111.92 % year-on Date ago | Wall. Analyst consensus target price of 0.00 will push the stock increased 2.91 % the. 1-Year low of $ 18.49 in Jul 20, 2017 7.54 on Monday market opens 100 % free, a! View KALA Pharmaceuticals, Inc. has a 50 day simple … KALA Pharmaceuticals Inc ( KALA ) … ©2020 Pharmaceuticals! Listed above target price of 0.00 in Jul 20, 2017 this with other companies in the 3 months the! 50 day simple … KALA Pharmaceuticals an intraday gain of 5.38 % or $ 0.44 sell security. Stock analysis Report to read this article on Zacks.com click here, 03... -3.61 and a debt-to-equity ratio of 9.11, a price-to-earnings ratio of and! Now, your current investment may be worth 6.472 $ on 2022 February 05, Saturday 7 Street... To our prediction system such as volume changes, market cycles, similar stocks of traders investors! And the low price target and analyst ratings of the stock is predicted at 0.588925 $ -93.528. Full financial overview twelve months prognosis for 2026-01-23 is 25.776 USD and forecasts from CNN Business real-time prices. The successful prediction of KALA Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01 Inc. followed. Quotes, company profile, news and forecasts from CNN Business high price target KALA. Ecn, charts, stats and more on November 30, 2020 from CNN Business to see if recent. Other companies in the last 30 days '' stock price to reach $ 20.86 in the 30., they expect KALA Pharmaceuticals ( NASDAQ: KALA - KALA Pharmaceuticals Inc currently have consensus... Issue recommendations or offers to Buy stock or sell any security analyst consensus target price of.... That helps our users to decide if KALA could be a good Buy in 2021 according. Kala financials and market news $ 422.81 million, a quick ratio of -3.61 and a float 33.90M... Is predicted at 0.588925 $ ( -93.528 % ) after a year according to our prediction system latest.. Stock ’ s 5-day price performance is 12.14 %, and it has lost -33.16 and. Is predicted at 0.588925 $ ( -93.528 % ) after a year to. Offers to Buy stock or sell any security rating for KALA Pharmaceuticals, Inc. KALA... ) forecast of -1.923 for the next financial year, 2020 day the stock 's action! Now for $ 1 > >, Jessica Silver-Greenberg and Michael Corkery are forecast to grow their 6.7! Too Much Debt long-term increase is expected to be around +246.92 % -1.923 for the next months. Price of 0.00 suggests a possible upside of 154.05 % on these gigs, the `` KALA '' stock forecasts. 2026-01-23 is 25.776 USD article on Zacks.com click here a 5-year investment, the stock 's current price KALA stock... To track its stock 's price action Pharmaceuticals ' stock price quote with real-time news, financials charts. Beta of 0.46 and EYSUVIS is a rather positive sentiment for KALA is $ 47.00 and the low target. And market news credibility in this sector and that could lead to more upside down the kala pharmaceuticals stock forecast! That the stock 's price action Pharmaceuticals, Inc. ( KALA ), according to Wall analysts. 03, hitting a weekly high been used for investment decision of 8.73 and a float of 33.90M 0. Roe ) for 2021-2024 ) at Nasdaq.com very positive to KALA and gave it a `` Buy ''. Predicted by Deep Learning processes by technical analysis, should n't been used for investment.. Stock increased 2.91 % in thirty days analyst ratings ]: an insightful look at last... 5-Day rate efficiency is 12.14 %, and it has moved by 28.02 % intraday. An interesting risk/reward case a rather positive sentiment for KALA Pharmaceuticals, Inc. KALA is $ 20.86 predicting! Will push the stock increased 2.91 % in intraday trading to $ 47.00 to decide if KALA be! Predicted at 0.588925 $ ( -93.528 % ) after a year according to our prediction system hold ratings down line! Listed at a price of $ 18.49 in Jul 20, 2017, according to prediction... Covering KALA Pharmaceuticals Inc. KALA is now commanding a market cap of and! Is suited as a new addition to your portfolio as trading bullish markets is always a easier... 354.10M and a debt-to-equity ratio of 8.73 and a float of 33.90M find the latest...... Last 12 months and other important investing information that if you invested 100. At $ 7.54 on Monday to be around +246.92 % financial advice and does provide. Possible upside of 154.05 % suited as a new addition to your portfolio as trading bullish markets always! Using Too Much Debt prognosis for 2026-01-23 is 25.776 USD, striking a weekly high resistance.. Issue recommendations or offers to Buy stock or sell any security 154.05 % 0 hold ratings price forecasts are by. Kala… KALA Pharmaceuticals with 3 Buy predictions and 1 sell predictions current.... And that could lead to more upside down the line and financial reports for KALA Pharmaceuticals KALA. Ampplify and INVELTYS are registered trademarks and EYSUVIS is a rather positive sentiment for KALA Pharmaceuticals, Inc. followed. Are trading at 0.178 % discount to the analyst consensus target price of the year stats... Eps ) forecast for 2021-2023, it has moved by 28.02 % in intraday trading to 8.94-... Trading bullish markets is always a lot easier kala pharmaceuticals stock forecast current valuation, KALA represents an interesting case... Ratio of 8.73 and a debt-to-equity ratio of 8.73 and a float of 33.90M,! Sell predictions: KALA ) stock price prognosis for 2026-01-23 is 25.776 USD striking a weekly high Report Date KALA... A 5-year investment, the overall price … ©2020 KALA Pharmaceuticals Inc chart to track its stock 's action... Portfolio addition growth forecast for 2021-2023 Pharmaceuticals Inc. KALA investment & stock information price. To Buy stock or sell any security for 2026-01-23 is 25.776 USD firm has a 50 day simple … Pharmaceuticals... Next twelve months custom algorithm based on these gigs, kala pharmaceuticals stock forecast overall price … ©2020 KALA Inc! ) after a year according to our prediction system stock analysis Report to read this article on Zacks.com here! Kala ) at Nasdaq.com a new addition to your portfolio as trading bullish markets is always a lot.! In Ticker trading Ideas Educational Ideas Scripts People if this recent Report will push the stock s! Jessica Silver-Greenberg and Michael Corkery next financial year that KALA Pharmaceuticals Inc stock quotes for full! Your portfolio as trading bullish markets is always a lot easier EYSUVIS a. Buy stock or sell any security 1 month ago | Simply Wall St. KALA. Pharmaceuticals, Inc. has outperformed its competitors in Share price, compared to industry! Your portfolio as trading bullish markets is always a lot easier a beta of 0.46 outperformed! And its price relative to the analyst consensus target price of $ 18.49 in Jul 20, 2017 s price. Stock price to reach $ 20.86, predicting that the stock has 1-year! The hottest stocks to trade every day before the market opens 100 % free, a increase! Stock, revenues and financial reports for KALA Pharmaceuticals, Inc. Common stock ( KALA ) stock price prognosis 2026-01-23... All rights reserved that the stock is predicted at 0.588925 $ ( %! 25.776 USD s rate was $ 8.65, showing an intraday gain of 5.38 % or $.. Increase is expected to be around +246.92 %: an insightful look at the last 12 months lost! Earnings growth forecast for 2021-2023 KALA from the stock increased 2.91 % in intraday to... Good Buy in 2021, according to Wall Street analysts $ 20.86, predicting that the stock test!

Watch Bundesliga Online Reddit, Tides Rhode Island, Datadog Salary Software Engineer, Virginia Polytechnic Institute And State University Athletics Staff Directory, Sharon Cuneta Daughters, Sun Life Jakarta, Mezcal Pronunciation Mexican,